Covid-19: Can our vaccine fight new strains? India to test | India News – Times of India
PUNE: The efficacy of the two Indian vaccines currently in use — Covishield and Covaxin — is likely to be tested against the Brazil and South Africa variants soon, scientists have said.
The Indian Council of Medical Research (ICMR) had announced on Tuesday that Pune-based National Institute of Virology was in the process of isolating and culturing the South African variant in its lab. The NIV has already readied a culture of the Brazilian variant for testing.
“Serum samples drawn from those who have received the vaccines in India will be used in the lab to test if they can neutralise the two variants that recently entered India,” said Dr Samiran Panda, head of ICMR’s epidemiology and communicable diseases division.
The South African variant is also known as 501.V2. The Brazilian one has been tagged as P.1. So far, India has recorded four Covid-positive cases with the South African variant and one with the Brazilian variant. “It is not necessary that a variant that is more transmissible will turn out to be more virulent. Another question to ask is whether they are associated with rapidly spreading outbreaks,” said Dr Panda.
Dr Sujeet Kumar Singh, director of National Centre for Disease Control, said the South African and Brazilian variants have public health implications.
“For one, the Brazilian variant is believed to be more transmissible and it may have the ability to evade antibodies,” he said. Studies show the South African variant too is more transmissible.Dr Singh did not disclose the locations in the country that reported cases with the mutated versions.
The Indian Council of Medical Research (ICMR) had announced on Tuesday that Pune-based National Institute of Virology was in the process of isolating and culturing the South African variant in its lab. The NIV has already readied a culture of the Brazilian variant for testing.
“Serum samples drawn from those who have received the vaccines in India will be used in the lab to test if they can neutralise the two variants that recently entered India,” said Dr Samiran Panda, head of ICMR’s epidemiology and communicable diseases division.
The South African variant is also known as 501.V2. The Brazilian one has been tagged as P.1. So far, India has recorded four Covid-positive cases with the South African variant and one with the Brazilian variant. “It is not necessary that a variant that is more transmissible will turn out to be more virulent. Another question to ask is whether they are associated with rapidly spreading outbreaks,” said Dr Panda.
Dr Sujeet Kumar Singh, director of National Centre for Disease Control, said the South African and Brazilian variants have public health implications.
“For one, the Brazilian variant is believed to be more transmissible and it may have the ability to evade antibodies,” he said. Studies show the South African variant too is more transmissible.Dr Singh did not disclose the locations in the country that reported cases with the mutated versions.
